Selecting colorectal cancer (CRC) patients for therapy based on mutational analysis by next generation sequencing: Are we analyzing the appropriate tumor? Background: Colorectal cancer with deficient ...
Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab. Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results